The role of insulin-like growth factor binding protein-3 in the growth inhibitory actions of androgens in LNCaP human prostate cancer cells. [electronic resource]
- International journal of cancer Feb 2008
- 558-66 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
1097-0215
10.1002/ijc.23100 doi
Blotting, Western Calcitriol--pharmacology Calcium Channel Agonists--pharmacology Cell Line, Tumor Drug Synergism Humans Insulin-Like Growth Factor Binding Protein 3--biosynthesis Male Metribolone--pharmacology Neoplasms, Hormone-Dependent--drug therapy Prostatic Neoplasms--drug therapy Reverse Transcriptase Polymerase Chain Reaction Transfection Up-Regulation--drug effects